http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108558771-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-30 |
| filingDate | 2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108558771-B |
| titleOfInvention | A kind of antitumoral compounds and its synthetic method and application |
| abstract | The present invention provides a kind of antitumoral compounds, chemical name is the bromo- 2- hydroxyl m-terephthal aldehyde two [ (1- methyl-1 H- benzimidazolyl-2 radicals-yl) hydrazone ] of 5-；The anti-tumor drug can be used for preparing the antitumor drug for having related disorders, such as the drug of Huppert's disease, lymthoma, leukaemia, lung cancer, liver cancer.It is active to various tumor cell strains the present invention provides a kind of completely new small molecule, anti-tumor drug, there is apparent anti-tumor activity, and safety is good. |
| priorityDate | 2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 599.